Him & Hers Health, a telehealth company, is doing something different with its Super Bowl ad this year. Instead of following the trend of promoting fast food and snacks, their new commercial focuses on weight loss.
The ad is scheduled to air during the third quarter of Super Bowl LIX on Fox on February 9. It aims to raise awareness about the company’s affordable weight-loss medications.
Him & Hers Health provides a variety of drugs designed to aid weight loss. Some of these medications contain Semaglutide, which is also found in well-known drugs like Ozempic and Wegovy.
The one-minute commercial starts with a narrator stating, ‘Obesity is America’s deadliest epidemic,’ while Childish Gambino’s ‘This Is America’ plays in the background.
The ad then runs through images of people’s bodies, aisles of junk foods, and the scale.
The narrator went on to say that 74 percent of of Americans are overweight, and that obesity leads to half a million deaths in the United States.
‘Something’s broken, and it’s not our bodies – it’s the system,’ the narrator continues.
‘Welcome to weight-loss in America, a $160 billion industry that feeds on our failure,’ they say.
The advertisement flashed even more photos of images that are associated with the diet industry, like an old magazine cover that read, ‘How to get a bikini body!’
‘There are medications that work, but they’re priced for profit, not patients,’ the advertisement continues.
‘This system wasn’t built to help us, it was built to keep us sick and stuck,’ the narrator boldly claims, before the commercial begins to advertise and promote the affordable weight-loss medication by the company.
Him & Hers also claimed in the ad that their medication is formulated in the United States.
On the website, the Hers Weight Loss Treatment Medication Kits are marketed as starting at just $69 per month, while their Seamglutide compound starts at $165.
‘We don’t have the budgets of Allstate. We don’t have the budgets of Geico,’ Dan Kenger, chief designer officer of Hims & Hers, told Variety during a recent interview.
‘If you can’t fight the fight, just fight a different fight, you know? And I think that’s what we are trying to do here, trying to zig where everyone else zags.’ he continued.
Kenger also shared that their goal is to get people to know their company, since they are younger brand, founded in 2017.
‘We want to come up as a bit of an underdog, a smaller company in the healthcare industry,’ the chief designer officer told the outlet.
‘We are very young, and we are doing innovative things,’ he continued. ‘And I think if people lead with that and understand that we’re a cool-looking brand that that is modern and understands how people want to deal with these conditions today, I think that’s the win for us.’
Over the past few years, GLP-1 medications, which have historically been used to treat type 2 diabetes, have become extremely popularized as a weight-loss aid after they were approved by the FDA.
Ozempic contains a compound called semaglutide, which ‘mimics the GLP-1’ hormone, according to UCLA Health, a hormone that can work with your brain to suppress your appetite and make you feel fuller more quickly.
When it’s taken in a high dose, combined with diet and exercise, it can help people lose weight.
In Hollywood, it’s particularly taken off, with celebrities like Oprah Winfrey, Sharon Osbourne, and Rebel Wilson all having admitted to taking a weight loss drug.
Some doctors, patients, and studies have reported various side effects of the drugs.
SHOPPING – Contains affiliated content. Products featured in this article are selected by our shopping writers. If you make a purchase using links on this page, DailyMail.com will earn an affiliate commission. Click here for more information.
